FULCRUM THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
FULCRUM THERAPEUTICS, INC. (FULC) had Stock Issued During Period, Shares, New Issues of 11.85 million shares as of 2025-12-31, per its S-4 filed 2026-09-02.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-09-02
- 2025-12-31: Stock Issued During Period, Shares, New Issues 11.85M shares.
- 2023-01-31: Stock Issued During Period, Shares, New Issues 9.62M shares; Stock Issued During Period, Shares, New Issues 1 month 9.62M shares.
- 2022-08-31: Stock Issued During Period, Shares, New Issues 11.03M shares.
- 2021-08-16: Stock Issued During Period, Shares, New Issues 7.59M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|
| 2025-12-31 | 11.85M shares S-4 · filed 2026-09-02 | |
| 2023-01-31 | 9.62M shares 10-K · filed 2025-02-25 | 9.62M shares 10-Q · filed 2024-11-13 |
| 2022-08-31 | 11.03M shares 10-K · filed 2024-02-27 | |
| 2021-08-16 | 7.59M shares 10-K/A · filed 2023-06-26 | |
| 2021-01-22 | 4.60M shares 10-K/A · filed 2023-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |